KIMBERLEE FLETCHER: Open Payments
NPI 1962944728 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,560 in 51 payments from 15 companies in 2025. Trend: 2023 $852 · 2024 $2,038 · 2025 $1,560
Food & beverage: $1,010Travel & lodging: $550
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 9 | $682 |
| Novo Nordisk Inc | 11 | $220 |
| SANOFI-AVENTIS U.S. LLC | 4 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $95 |
| Abbott Laboratories | 4 | $88 |
| Dexcom, Inc. | 3 | $62 |
| Corcept Therapeutics | 3 | $60 |
| Lilly USA, LLC | 3 | $58 |
| Amgen Inc. | 2 | $36 |
| Ascendis Pharma Endocrinology Inc | 2 | $35 |
Products named: MINIMED 780G, Rybelsus, TZIELD, Ozempic, JARDIANCE, FREESTYLE LIBRE, Dexcom G6 Transmitter, Korlym.
Industry payments across GA — which companies pay providers there.
